Table of Contents
<< Previous Issue | May 2004 (Vol: 2004, Issue: 47) | Next Issue >> |
- Section: Company Profile
-
Eurand
- Section: Distribution & Marketing
-
Elan Streamlines CNS Portfolio with Divestment of Two Drugs
- Section: Licensing
-
Schering-Plough Licenses Toyama’s Antibacterial Agent
- Section: Mergers & Acquisitions
-
Amgen Boosts Long-Term Pipeline with US$1.3 B Tularik Acquisition
- Section: Research & Development
-
Roche Endorses ArQule’s Oncology Platform with US$276 M Alliance
-
Wyeth and Solvay Form Neuroscience Collaboration